Springer Nature AG & Co KgaA (SPGG)

Currency in EUR
22.800
-0.200(-0.87%)
Delayed Data·
SPGG is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
22.50023.500
52 wk Range
14.70023.550
Key Statistics
Bid/Ask
22.75 / 22.90
Prev. Close
23
Open
23.5
Day's Range
22.5-23.5
52 wk Range
14.7-23.55
Volume
8.48K
Average Volume (3m)
42.37K
1-Year Change
13.4328%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
SPGG Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
27.000
Upside
+18.42%
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a low P/E ratio relative to near-term earnings growth
Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Buy
Moving Averages
Strong Buy

Analyst Ratings

8 Buy
1 Hold
0 Sell
Ratings:
9 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 27.000
(+18.42% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Barclays
Buy26.00+14.04%25.15MaintainNov 18, 2026
Citi
Buy28.20+23.68%27.00MaintainNov 18, 2026
Citi
Buy27.00+18.42%-New CoverageOct 20, 2026
Barclays
Buy25.15+10.31%24.80MaintainOct 09, 2026
Kepler Cheuvreux
Buy360.00+1,478.95%340.00MaintainSep 04, 2026

Springer Nature AG & Co KgaA Earnings Call Summary for Q3/2026

  • Springer Nature posted 6% underlying revenue growth and 8% adjusted operating profit growth for nine months, raising full-year guidance to at least 6% revenue growth.
  • Free cash flow surged to EUR 244 million, up EUR 69 million year-over-year; net debt to EBITDA improved to 1.6x from 3.0x at IPO.
  • Research division drove results with 7% revenue growth; company completed consumer media sale to sharpen focus on core academic publishing business.
  • Nature Research Assistant AI tool set for early 2027 launch focused on user growth rather than immediate monetization; no major revenue expected next year.
  • Shares slipped 0.66% to $22.65 despite raised guidance; U.S. regulatory uncertainty and AI monetization timing remain key investor concerns.
Last Updated: 11/17/2026, 09:54 PM
Read Full Transcript

Earnings

Latest Release
Nov 16, 2026
EPS / Forecast
0.51 / 0.50
Revenue / Forecast
529.65M / 521.42M
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 1.65
Dividend Yield
3.61%
Industry Median 2.29%
Annualized payout
0.83
Paid annually
5-Years Growth
-
Growth Streak

SPGG Income Statement

Compare SPGG to Peers and Sector

Metrics to compare
SPGG
Peers
Sector
Relationship
P/E Ratio
14.1x16.5x5.3x
PEG Ratio
0.140.030.01
Price/Book
2.3x2.3x1.8x
Price / LTM Sales
2.4x1.2x1.2x
Upside (Analyst Target)
18.4%83.7%32.2%
Fair Value Upside
Unlock16.0%20.0%Unlock

Springer Nature AG & Co. KGaA, together with its subsidiaries, engages in the publishing business in Germany, the United Kingdom, the United States, and internationally. The company operates through three segments: Research, Education, and Health. It offers journals across various academic disciplines under the Nature Portfolio and Springer brand names; books in print and digital formats across various scientific disciplines, including monographs, textbooks, conference proceedings, handbook series, reference works, and briefs under the Springer and Palgrave Macmillan brand names; and support services to researchers, institutions, and industry professionals with AI-powered tools and services, such as AdisInsight, Springer Nature Experiments, protocols.io, and SpringerMaterials, as well as professional development and career services under the Nature Masterclasses, Nature Careers, and Nature Conferences brand names. The company also provides English language teaching content and national curricula learning resources under the Macmillan Education brand name. In addition, it offers specialist information and services to healthcare professionals under the Springer Medizin brand name; publications, learning solutions, and professional services to healthcare practitioners and students under the BSL brand name; content and services related to drug treatments, medical devices, and diagnostics under the Springer Health+ brand name; and Cureus Journal of Medical Science, a peer-reviewed OA medical journal. The company was founded in 1842 and is based in Berlin, Germany. Springer Nature AG & Co. KGaA operates as a subsidiary of GvH Vermögensverwaltungsgesellschaft Xxxiii mbH.

Employees
9400
Market
Germany

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
12.13M6.10%276.46M
Other Institutional Investors
178.35M89.67%4.07B
Public Companies & Retail Investors
8.41M4.23%191.82M
Total
198.89M100.00%4.53B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Georg von Holtzbrinck GmbH & Co. KG50.60%100,637,8302,294,543
Springer Science+business Media Galileo Participation S.a R.l.36.00%71,600,0371,632,481

People Also Watch

61.250
EVDG
-0.24%
574.40
MUVGn
-1.31%
320.100
DB1Gn
-1.17%
85.62
WLSNc
-0.05%
39.460
NDXG
+0.92%

FAQ

What Is the Springer Nature (SPGG) Stock Price Today?

The Springer Nature stock price today is 22.800 EUR.

What Stock Exchange Does Springer Nature Trade On?

Springer Nature is listed and trades on the Frankfurt Stock Exchange.

What Is the Stock Symbol for Springer Nature?

The stock symbol for Springer Nature is "SPGG."

Does Springer Nature Pay Dividends? What’s The Current Dividend Yield?

The Springer Nature dividend yield is 3.6%%.

What Is the Springer Nature Market Cap?

As of today, Springer Nature market cap is 4.570B EUR.

What Is Springer Nature's Earnings Per Share (TTM)?

The Springer Nature EPS (TTM) is 1.65.

When Is the Next Springer Nature Earnings Date?

Springer Nature will release its next earnings report on Mar 23, 2027.

From a Technical Analysis Perspective, Is SPGG a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Springer Nature Stock Split?

Springer Nature has split 0 times.

How Many Employees Does Springer Nature Have?

Springer Nature has 9400 employees.

What is the current trading status of Springer Nature (SPGG)?

As of Nov 19, 2026, Springer Nature (SPGG) is trading at a price of 22.800 EUR, with a previous close of 23.000 EUR. The stock has fluctuated within a day range of 22.500 EUR to 23.500 EUR, while its 52-week range spans from 14.700 EUR to 23.550 EUR.

What Is Springer Nature (SPGG) Price Target According to Analysts?

The average 12-month price target for Springer Nature is 27.000 EUR, with a high estimate of 32.4 EUR and a low estimate of 20.5 EUR. 8 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +18.42% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.